A high-resolution ‘map’ reveals the structural and functional complexity of endogenous NMDA receptors in the brain

In a study published in Cell, a research team led by Zhu Shujia from the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences (CAS), along with Li Yang from the Shanghai Institute of Materia Medica of CAS, has dissected the assembly and architecture of endogenous N-methyl-ᴅ-aspartate receptors (eNMDARs) in the adult mammalian cerebral cortex and hippocampus.
Read More

Sapio Sciences Obtient la Certification Hébergeur de Données de Santé (HDS)

BALTIMORE–(BUSINESS WIRE)–Sapio Sciences, la plateforme d’informatique de laboratoire science-aware™, a annoncé aujourd’hui l’obtention de la certification Hébergeur de Données de Santé (HDS), une exigence obligatoire pour les organisations hébergeant des données personnelles de santé en France. L’obtention de la certification HDS souligne la conformité de Sapio Sciences aux normes strictes de sécurité, de confidentialité et de continuité opérationnelle. Cet accomplissement réaffirme l’engage
Read More

Blood vessel on-a-chip identifies how perivascular cells can worsen chronic disease

Researchers at Oregon Health & Science University have uncovered how specialized cells surrounding small blood vessels, known as perivascular cells, contribute to blood vessel dysfunction in chronic diseases such as cancer, diabetes and fibrosis. The findings, published today in Science Advances, could change how these diseases are treated.
Read More

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors

BEIJING & ALAMEDA, Calif. & TAIPEI–(BUSINESS WIRE)– #Acepodia–Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This collaboration combines Biocytogen’s RenLite® platform with Acepodia’s Antibody-Dual-Drugs Conjugation (AD2C) technology to tackle some of the toughest challenges in oncology—tumor heterogeneity and drug resistance. This novel approach aims to address
Read More
Top